Webinar | Particle To Patient: Overcoming Challenges In Generic Metered Dose Inhaler Development




Date: Tuesday, May 10, 2016
Time:  10:00 am ET / 3:00 pm GMT

Register today.

Through expert content and case study examples this webinar will highlight strategies and capabilities required to reliably develop a generic MDI.

Key Learning Objectives

  • Increase understanding of key elements of MDI product performance to must be met for a generic MDI
  • Review of relevant FDA guidance’s
  • Understanding of micronization process development and API characteristics
  • Key factors in IVBE study design

Speakers: Craig Davies-Cutting, Ph.D,Director, Inhaled Products & Technologies, Catalent Pharma Solutions
Carole Evans, Ph.D,,Director Inhalation Business Operations, Catalent Pharma Solutions 

Register today.

お問い合わせ

    メールボックス
    japan.sales@catalent.com

    東京オフィス
    〒107‐0052
    東京都港区赤坂4−9−17
    T (03) 3470-2311
    F (03) 3408-5554

    掛川工場
    〒436‐0341
    静岡県掛川市倉真1656
    T(0537) 29-1131